Acquisition of mixed lineage leukemia rearrangement in a chronic myeloid leukemia patient while on imatinib

Hematology Reports

Volumn 3, Issue 2, 2011, Pages 37-38

  Zámečníkova, Adriana ^a  

^a KUWAIT CANCER CONTROL CENTER   (Kuwait)

Author keywords

CML progression; Imatinib treatment; MLL rearrengment

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN; HYDROXYUREA; IMATINIB; MIXED LINEAGE LEUKEMIA PROTEIN; NILOTINIB;

ADULT; ARTICLE; BLOOD ANALYSIS; BONE MARROW BIOPSY; CANCER MORTALITY; CANCER REGRESSION; CASE REPORT; CHROMOSOME 11Q; CHROMOSOME 19P; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 19; CHRONIC MYELOID LEUKEMIA; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FEVER; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HUMAN; LEUKOCYTOSIS; PHILADELPHIA 1 CHROMOSOME; TACHYCARDIA;

EID: 80052683427     PISSN: 20388322     EISSN: 20388330     Source Type: Journal    
DOI: 10.4081/hr.2011.e13     Document Type: Article

References (10)

1. Barbouti A, Johansson B, Höglund M, Mauritzson N, et al. Multicolor COBRA-FISH analysis of chronic myeloid leukemia reveals novel cryptic balanced translocations during disease progression. Genes Chromosomes Cancer 2002;35:127-137.
2. Nishii K, Usui E, Sakakura M, Miyata E, et al. Additional t(11;17)(q23;q21) in a patient with Philadelphia-positive mixed lineage antigen-expressing leukemia. Cancer Genet Cytogenet 2001;1;126:8-12.
3. Otero L, Moellmann AC, Pombo-de-Oliveira MS, Ornellas MH, et al. Additional t(1;11)(q21;q23) with mixed lineage leukemia rearrangement in T-blastic crisis of a Ph-positive chronic myeloid leukemia. Eur J Haematol 2007;79:179-181.
4. Royer-Pokora B, Hildebrandt B, Redmann A, Herold C, et al. Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment. Leukemia 2003;17: 807-810.
5. Moorman AV, Hagemeijer A, Charrin C, Rieder H, Secker-Walker LM. The translo-cations, t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3): a cytogenetic and clinical profile of 53 patients. Leukemia. 1998;12:805-10
6. Huret JL. t(11;19)(q23;p13.1). Atlas Genet Cytogenet Oncol Haematol. December 1997.URL: http://AtlasGeneticsOncology. org/Anomalies/t1119ELL.html
7. DiMartino JF, Miller T, Ayton PM, Landewe T, et al. A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL. Blood 2000;96:3887-93.
8. Lavau C, Luo RT, Du Ch, Thirman MJ. Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice. Proc Natl Acad Sci USA 2000; 26:97:10984-9.
9. Suzuki K, Sugawara T, Kowata S, Utsugizawa T, et al. Uncommon karyotypic abnormality, t(11;19)(q23;p13.3), in a patient with blastic phase of chronic myeloid leukemia. Cancer Genet Cytogenet 2004;150:159-63.
10. Lisa G. Shaffer et al. ISCN 2009; An international system for human cytogenetic nomenclature (2009). S. Karger AG, 2009.